- Home
- NAUT vs VTGN Comparison
NAUT vs VTGN Comparison
Compare NAUT & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAUT
- VTGN
- Stock Information
- Founded
- NAUT 2016
- VTGN 1998
- Country
- NAUT United States
- VTGN United States
- Employees
- NAUT N/A
- VTGN N/A
- Industry
- NAUT Biotechnology: Laboratory Analytical Instruments
- VTGN Biotechnology: Pharmaceutical Preparations
- Sector
- NAUT Industrials
- VTGN Health Care
- Exchange
- NAUT Nasdaq
- VTGN Nasdaq
- Market Cap
- NAUT 104.7M
- VTGN 87.2M
- IPO Year
- NAUT N/A
- VTGN N/A
- Fundamental
- Price
- NAUT $0.90
- VTGN $4.10
- Analyst Decision
- NAUT Strong Sell
- VTGN
- Analyst Count
- NAUT 1
- VTGN 0
- Target Price
- NAUT $1.75
- VTGN N/A
- AVG Volume (30 Days)
- NAUT 394.7K
- VTGN 582.6K
- Earning Date
- NAUT 10-28-2025
- VTGN 11-06-2025
- Dividend Yield
- NAUT N/A
- VTGN N/A
- EPS Growth
- NAUT N/A
- VTGN N/A
- EPS
- NAUT N/A
- VTGN N/A
- Revenue
- NAUT N/A
- VTGN $646,000.00
- Revenue This Year
- NAUT N/A
- VTGN $10.19
- Revenue Next Year
- NAUT N/A
- VTGN $705.79
- P/E Ratio
- NAUT N/A
- VTGN N/A
- Revenue Growth
- NAUT N/A
- VTGN N/A
- 52 Week Low
- NAUT $0.62
- VTGN $1.90
- 52 Week High
- NAUT $3.03
- VTGN $4.25
- Technical
- Relative Strength Index (RSI)
- NAUT 60.66
- VTGN 70.98
- Support Level
- NAUT $0.69
- VTGN $3.44
- Resistance Level
- NAUT $0.92
- VTGN $3.75
- Average True Range (ATR)
- NAUT 0.06
- VTGN 0.25
- MACD
- NAUT 0.01
- VTGN 0.05
- Stochastic Oscillator
- NAUT 70.67
- VTGN 81.11
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.